John Leaman - Oct 19, 2021 Form 4 Insider Report for IMPEL NEUROPHARMA INC (IMPL)

Role
Chief Fin. & Business Officer
Signature
/s/ John Leaman, M.D.
Stock symbol
IMPL
Transactions as of
Oct 19, 2021
Transactions value $
$0
Form type
4
Date filed
10/21/2021, 05:31 PM
Previous filing
Jul 26, 2021
Next filing
Jan 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Restricted Stock Units (RSUs) Award $0 +10.6K $0.00 10.6K Oct 19, 2021 Common Stock 10.6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2 The RSUs vest as to 100% of the total shares on December 31, 2022, subject to the reporting person's continuation of employment on such vesting date.